Abstract European Guidelines for Quality Assurance in Cervical Cancer Screening have
been initiated in the Europe Against Cancer Programme. The first edition established the …

Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the
second most common cause of death from cancer among women worldwide. This Review …

The papillomavirus major late protein, L1, forms the pentameric assembly unit of the viral
shell. Recombinant HPV16 L1 pentamers assemble in vitro into capsid-like structures, and …

Papillomaviruses replicate in stratified epithelia of skin and mucosa. Infection with certain
human papillomavirus (HPV) types is the main cause of anogenital neoplasia, in particular …

Sensitive high-throughput neutralization assays, based upon pseudoviruses carrying a
secreted alkaline phosphatase (SEAP) reporter gene, were developed and validated for …

Cancer of the uterine cervix is the second largest cause of cancer deaths in women, and its
toll is greatest in populations that lack screening programmes to detect precursor lesions …

Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

The human papillomavirus (HPV) capsid consists of 360 copies of the major capsid protein,
L1, arranged as 72 pentamers on a T= 7 icosahedral lattice, with substoichiometric amounts …

This review discusses diseases of the lower genital tract in which the presence of human
papillomavirus (HPV) DNA is well documented. We discuss epidemiologic, clinical, and …

Interest in coinfection with multiple types of human papillomavirus (HPV) has increased in
response to the possibility of vaccination and the discovery that the host immune response …